EUVIMEDEUVIMED entdecken
Crossref

An In Vitro Model of Hematotoxicity: Differentiation of Bone Marrow–Derived Stem/Progenitor Cells into Hematopoietic Lineages and Evaluation of Lineage‐Specific Hematotoxicity

Prathap Kumar Mahalingaiah, Tammy Palenski, Terry R Van Vleet

Current Protocols in Toxicology · 2018-05 · 76 (1)

DOI: 10.1002/cptx.45 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Protocols in Toxicology, online erschienen am 30.04.2018. Verfasst von Prathap Kumar Mahalingaiah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Investigative Toxicology and Pathology Department, Preclinical Safety, AbbVie Inc., North Chicago, Illinois. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hematotoxicity is a significant issue for drug safety and can result from direct cytotoxicity toward circulating mature blood cell types as well as targeting of immature blood‐forming stem cells/progenitor cells in the bone marrow. In vitro models for understanding and investigating the hematotoxicity potential of new test items/drugs are critical in early preclinical drug development. The traditional method, colony forming unit (CFU) assay, is commonly used and has been validated as a method for hematotoxicity screening. The CFU assay has multiple limitations for its application in investigative work. In this paper, we describe a detailed protocol for a liquid‐culture, microplate‐based in vitro hematotoxicity assay to evaluate lineage‐specific (myeloid, erythroid, and megakaryocytic) hematotoxicity at different stages of differentiation. This assay has multiple advantages over the traditional CFU assay, including being suitable for high‐throughput screening and flexible enough to allow inclusion of additional endpoints for mechanistic studies. Therefore, it is an extremely useful tool for scientists in pharmaceutical discovery and development. © 2018 by John Wiley & Sons, Inc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Marrow CellsCell DifferentiationCell LineageHematopoietic Stem CellsHumansIn Vitro TechniquesToxicity Tests

Stichwörter der Autor:innen

CD34+ cellshematopoietic stem/progenitor cellshematotoxicityin vitro model

Autor:innen und Institutionen

  • Investigative Toxicology and Pathology Department, Preclinical Safety, AbbVie Inc., North Chicago, Illinois.
  • Clinical Oncology Department, AbbVie Inc., North Chicago, Illinois.

Zitieren

APA

Mahalingaiah, P. K., Palenski, T., & Van Vleet, T. R. (2018). An In Vitro Model of Hematotoxicity: Differentiation of Bone Marrow–Derived Stem/Progenitor Cells into Hematopoietic Lineages and Evaluation of Lineage‐Specific Hematotoxicity. Current Protocols in Toxicology, 76(1). https://doi.org/10.1002/cptx.45

Vancouver

Mahalingaiah PK, Palenski T, Van Vleet TR. An In Vitro Model of Hematotoxicity: Differentiation of Bone Marrow–Derived Stem/Progenitor Cells into Hematopoietic Lineages and Evaluation of Lineage‐Specific Hematotoxicity. Current Protocols in Toxicology. 2018;76(1). doi:10.1002/cptx.45

BibTeX
@article{Mahalingaiah2018,
  author = {Mahalingaiah, Prathap Kumar and Palenski, Tammy and Van Vleet, Terry R},
  title = {An In Vitro Model of Hematotoxicity: Differentiation of Bone Marrow–Derived Stem/Progenitor Cells into Hematopoietic Lineages and Evaluation of Lineage‐Specific Hematotoxicity},
  journal = {Current Protocols in Toxicology},
  year = {2018},
  volume = {76},
  number = {1},
  doi = {10.1002/cptx.45}
}
Kostenlos starten →